Annual Gene Therapy Symposium for
Heart, Lung, and Blood Diseases
Home
Information for
Trainees
Register Online
2017
Past Symposia:
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002

UC Davis

 


13th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases
Focus Topic: Genomic Editing
November 19-21, 2014 - Sonoma, California

Student/Fellow Presentations

 
 

Thursday, November 20, 2014


 
 
Yogesh K. Dhande, M.S.
Colin M. Exline, Ph.D.
 
 
Yogesh K. Dhande, M.S.
(University of Minnesota)
“Cationic Diblock Glycopolymers for Liver-targeted Gene Transfer”

Colin M. Exline, Ph.D.
(University of Southern California)
“High Efficiency Site-specific Gene Addition in Hematopoietic Stem Cells using AAV Vectors”
 
 
Haley R. Phillips, M.S.
Laura Smith, B.S.
 
 
Haley R. Phillips, M.S.
(University of Minnesota)
“Hemocompatibility of Colloidally Stable Glycopolymer-DNA Complexes for Gene Therapy”
Laura Smith, B.S.
(City of Hope)
“Efficient Targeted Integration into AAVS1 by AAVHSC Vectors Encoding Zinc-Finger Nucleases”

 
 
Andrea Wong, B.A.
 
 
 
Andrea Wong, B.A.
(City of Hope)
“Using CRISPR to Target Mitochondrial DNA (mtDNA)””



 
 
 
 
 

Friday, November 21, 2014


 
 
Raul S. Copaciu, B.S.
Phillip A. Doerfler, B.S.
 
 
Raul S. Copaciu, B.S.
(California State University, Sacramento)
“Induction of an Augmented Pacemaking Cardiomyocyte Population from Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells”

Phillip A. Doerfler, B.S.
(University of Florida)
“Dual AAV9 Vectors Improve Cardiac and Skeletal Muscle Function with Amelioration of Immune Responses in Pompe Mice”
 
 
Amy L. Donate, Ph.D.
Rachel T. Hatano, B.S.
 
 
Amy L. Donate, Ph.D.
(University of Florida)
“Treatment of Barth Syndrome by AAV-TAZ”

Rachel T. Hatano, B.S.
(University of California, Merced)
“Engineering the Mechanical Microenvironment: Towards Fabrication of a Stem Cell-Derived Cardiac Patch”
 
 
Suzan Imren, M.D.
   
 
Suzan Imren, M.D.
(Terry Fox Laboratory)
“Small Molecules for Enhanced Yield of Genetically Modified Hematopoietic Stem Cells”